The genetic association of FTO variants with metabolic traits in patients with schizophrenia may be modified by antipsychotics

J Clin Psychopharmacol. 2014 Feb;34(1):162-5. doi: 10.1097/JCP.0b013e3182a95b20.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO
  • Antipsychotic Agents / adverse effects*
  • Biomarkers / blood
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Female
  • Genetic Predisposition to Disease
  • Genetic Variation*
  • Humans
  • Insulin / blood
  • Lipids / blood
  • Male
  • Middle Aged
  • Obesity / blood
  • Obesity / chemically induced*
  • Obesity / genetics*
  • Phenotype
  • Proteins / genetics*
  • Risk Factors
  • Schizophrenia / blood
  • Schizophrenia / diagnosis
  • Schizophrenia / drug therapy*
  • Schizophrenia / genetics
  • Schizophrenic Psychology*
  • Weight Gain / drug effects
  • Weight Gain / genetics
  • Young Adult

Substances

  • Antipsychotic Agents
  • Biomarkers
  • Blood Glucose
  • Insulin
  • Lipids
  • Proteins
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO
  • FTO protein, human